Objective: Our objective was to provide a scholarly review of the published literature on
menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …

Gastric cancer is the second most common cause of cancer death worldwide, and annually it
causes over 150,000 deaths in Europe and 700,000 deaths globally. The incidence of …

Background Following the release of the 2002 report of the Women's Health Initiative (WHI)
trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States …

BACKGROUND: The objective of this study was to provide updated estimates of national
trends in cancer incidence and mortality for France for 1980–2005. METHODS: Twenty-five …

Abstract Background Since the 1980s, Spain experienced two decades of sharply
increasing breast cancer incidence. Declines in breast cancer incidence have recently been …

Breast cancer is the most common cancer in women worldwide, comprising 23% of all
cancers, with more than 1 million new cases per year. 1 The main risk factors are related to …

Breast cancer is mainly a postmenopausal disease, but in younger women breast tumors
often exhibit more aggressive features and worse prognosis. Furthermore, high-risk and low …

An increase in the incidence of breast cancer in women aged< 40 years has been reported
in recent years. Increased incidence could be partly explained by subtle detection biases …

This ninety-first volume of IARC Monographscontains evaluations of the carcinogenic
hazard to humans of combined estrogen-progestogen contraceptives and combined …

Objective: Few studies have been conducted on breast cancer in Sub-Saharan Africa and
their results have been suspected to be impaired by artefacts. This prospective study was …